IS8249A - Tafla sem felur í sér flúvastatín og karmellósakalsíum - Google Patents

Tafla sem felur í sér flúvastatín og karmellósakalsíum

Info

Publication number
IS8249A
IS8249A IS8249A IS8249A IS8249A IS 8249 A IS8249 A IS 8249A IS 8249 A IS8249 A IS 8249A IS 8249 A IS8249 A IS 8249A IS 8249 A IS8249 A IS 8249A
Authority
IS
Iceland
Prior art keywords
tablet containing
carmellose calcium
fluvastatin
containing fluvastatin
containing tablet
Prior art date
Application number
IS8249A
Other languages
English (en)
Inventor
Uehara Tomoyuki
Taguchi Kenji
Kitaoka Kenichi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8249A publication Critical patent/IS8249A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
IS8249A 2003-06-25 2006-01-20 Tafla sem felur í sér flúvastatín og karmellósakalsíum IS8249A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25
PCT/EP2004/006865 WO2005000276A1 (en) 2003-06-25 2004-06-24 Tablet comprising fluvastatin and carmellose calcium

Publications (1)

Publication Number Publication Date
IS8249A true IS8249A (is) 2006-01-20

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8249A IS8249A (is) 2003-06-25 2006-01-20 Tafla sem felur í sér flúvastatín og karmellósakalsíum

Country Status (21)

Country Link
US (1) US20090117181A1 (is)
EP (1) EP1641440B1 (is)
KR (1) KR20060030480A (is)
CN (1) CN1809342A (is)
AT (1) ATE471713T1 (is)
AU (1) AU2004251439B2 (is)
BR (1) BRPI0411855A (is)
CA (1) CA2529447A1 (is)
CO (1) CO5650224A2 (is)
DE (1) DE602004027808D1 (is)
EC (1) ECSP056238A (is)
IL (1) IL172531A0 (is)
IS (1) IS8249A (is)
MA (1) MA27889A1 (is)
MX (1) MXPA05013943A (is)
NO (1) NO20060261L (is)
NZ (1) NZ544119A (is)
RU (1) RU2361582C2 (is)
TN (1) TNSN05330A1 (is)
WO (1) WO2005000276A1 (is)
ZA (1) ZA200509930B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101426478A (zh) * 2006-02-24 2009-05-06 特瓦制药工业有限公司 氟伐他汀钠药物组合物
WO2012049156A1 (en) * 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
JP5988963B2 (ja) 2011-04-12 2016-09-07 沢井製薬株式会社 ピタバスタチン含有製剤及びその製造方法
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
US20030060488A1 (en) * 2000-02-10 2003-03-27 Yasuo Sugiyama Drug comprising combination
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides

Also Published As

Publication number Publication date
RU2006101889A (ru) 2007-08-10
IL172531A0 (en) 2006-04-10
EP1641440B1 (en) 2010-06-23
AU2004251439A1 (en) 2005-01-06
KR20060030480A (ko) 2006-04-10
BRPI0411855A (pt) 2006-08-29
WO2005000276A1 (en) 2005-01-06
ECSP056238A (es) 2006-04-19
ATE471713T1 (de) 2010-07-15
AU2004251439B2 (en) 2008-09-11
CA2529447A1 (en) 2005-01-06
ZA200509930B (en) 2007-01-31
MA27889A1 (fr) 2006-05-02
NO20060261L (no) 2006-01-18
RU2361582C2 (ru) 2009-07-20
TNSN05330A1 (en) 2007-07-10
DE602004027808D1 (de) 2010-08-05
CN1809342A (zh) 2006-07-26
MXPA05013943A (es) 2006-02-24
NZ544119A (en) 2008-04-30
CO5650224A2 (es) 2006-06-30
US20090117181A1 (en) 2009-05-07
EP1641440A1 (en) 2006-04-05

Similar Documents

Publication Publication Date Title
ZA200409641B (en) Novel substituted indoles.
IS8249A (is) Tafla sem felur í sér flúvastatín og karmellósakalsíum
NO20052309D0 (no) Nutrasoytisk mangostanblanding.
GB0204771D0 (en) Fast disintegrating tablets
NO20041195L (no) Tablettmater.
ZA200604874B (en) Pharmaceutical compositions
SI1729794T1 (sl) Farmacevtski pripravek, ki vsebuje sulfobetain, ki nima lastnosti detergenta
EG23381A (en) Production of olefins.
EG23393A (en) Production of olefins.
AU2003295408A8 (en) Sulfonamides
AU2003291262A8 (en) Sulfonamides
NL1025055A1 (nl) Verbeterd lampontwerp.
NL1024812A1 (nl) Lampenkap.
GB0206407D0 (en) Ceiling socket-replacement for ceiling rose
ES1053557Y (es) Luminaria vertical empotrable.
ES1052333Y (es) Cajon premarco.
ZA200209660B (en) Lamp.
ES1051309Y (es) Desmenuzador de especias.
ES1052719Y (es) Lampara dinamica.
ZA200307036B (en) Lighting units.
ES1053421Y (es) Linterna.
ES1052131Y (es) Luminaria estanca mejorada.
SE0202435D0 (sv) Lykta, särskilt gravlykta
GB0227756D0 (en) P.H. tablet
ES1051628Y (es) Cuadro decorativo multipieza.